关键词: ABC AE Adverse events Bevacizumab Breast cancer CT EGFR Everolimus FDA Food and Drug Administration HER2 LVEF Lapatinib Pertuzumab QoL RCC T-DM1 Trastuzumab Trastuzumab emtansine Trastuzumab-emtansine VEGF advanced breast cancer adverse event computed tomography epidermal growth factor receptor human epidermal growth factor receptor type 2 left ventricular ejection fraction mTOR quality of life renal cell cancer the mammalian target of rapamycin vascular endothelial growth factor
Mesh : Ado-Trastuzumab Emtansine Angiogenesis Inhibitors / adverse effects Antibodies, Monoclonal, Humanized / adverse effects Antineoplastic Agents / adverse effects Bevacizumab Biological Therapy / adverse effects Breast Neoplasms / drug therapy Drug-Related Side Effects and Adverse Reactions / prevention & control Everolimus Humans Immunosuppressive Agents / adverse effects Lapatinib Maytansine / adverse effects analogs & derivatives Quinazolines / adverse effects Sirolimus / adverse effects analogs & derivatives Trastuzumab
来 源: DOI:10.1016/j.breast.2013.09.009